Line 1/IAAP- FWP
Quarterly Report
A
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
B
C
D
E
F
G
Former Worker Medical Screening Program Quarterly Report
Project Name
DOE Site
Project PI
Organization
Cooperative Agreement Number
Quarter/Year
Administrative Information
Initial Institutional IRB Approval Date
Continuing Institutional IRB Approval Date
Initial DOE Site IRB Approval Date
Continuing DOE Site IRB Approval Date
Initial CDOEIRB Approval Date
Continuing CDOEIRB Approval Date
Project Start Date
Screening Start Date
20 Estimated Eligible Population
21
Former Worker Medical Screening Program for the Iowa Army Ammunition Plant
Iowa Army Ammunition Plant
Lar Fuortes
University of Iowa College of Public Health
DE-FC01-06EH06020
Federal Quarter 4: July - September 2010
10/5/00
2/23/10
1/28/09
1/28/10
8/15/00
3/21/01
5,000
Page 1 of 8
Line 1/IAAP- FWP
Quarterly Report
A
22 Outreach Information
23 Outreach Goal for this FY
24
# of potential participants attempted to
25 contact directly
Mass mailings
26
mailing: invitation for
commemoration event- Sept 2010
27
___________________________
28
___________________________
29
30 Other forms of outreach
31 phone calls
32 word of mouth
33
Which of the outreach approaches is most
34 effective for your program?
direct mailings, phone calls, newspaper
articles & ads, Town Hall meetings, word of
35 mouth
36
37 Indicators of Interest in Program
38
39 Total Number of Respondents
Total Number of Respondents Interested
40 and Eligible
Total Number of Respondents Pre41 Authorized/Scheduled for Screening
42
B
1,000
This Quarter
C
D
This FY
Total to Date
0
0
E
F
G
3,837
881
This Quarter
This FY
37
12
12
Total to Date
102
30
30
1,785
1280
1,329
Page 2 of 8
Line 1/IAAP- FWP
Quarterly Report
A
B
C
D
This FY
Total to Date
E
F
G
43
44 Participation Indicators (initial screens)
45 Screening Goal for this FY
46
72
This Quarter
Total number received initial screening (total
47 combined through site-specific & NSSP)
14
63
1,265
Screened Through Primary/Site-Specific
Screened Through NSSP
9
5
42
21
1,183
82
48
49
50
51
52
53
54
55
56
On initial screen:
Mean/Average Age at Exam (Male)
Mean/Average Age at Exam (Female)
Age Range (Male)
Age Range (Female)
Through Site-specific Project
This Quarter
Total to Date
72.48
70.21
70.06
70.32
65 - 84
40 - 94
62 - 77
45 - 95
60 - 79
Through NSSP
This Quarter
Total to Date
71.00
72.00
75.00
56 - 86
61 - 86
Page 3 of 8
Line 1/IAAP- FWP
Quarterly Report
A
B
C
D
E
F
G
57
58 Lab Studies/Findings (initial screens)
59
60 Chest X-Rays (initial screens)
61 Total Number of Individuals Tested
Number with Suspected Asbestosis without
62 pleural disease
Number with Suspected Asbestosis with
63 pleural disease
Number with Suspected Asbestos-related
64 pleural disease
65 Number with Suspected Silicosis
Number with Suspected Mixed Dust
66 Pneumoconiosis
Number with Suspected Pneumoconiosis,
67 not otherwise specified
Number with Suspicious Lung Nodules,
68 Nodes, Lesions (suspicious for cancer)
69
Pulmonary Function Tests (initial
2
70 screens)
71 Total Number of Individuals Tested
72 Number with Restrictive Pattern
73 Number with Obstructive Pattern
74 Number with Mixed Pattern
Through Site-specific Project
This Quarter
9
0
Through NSSP
This FY
Total to Date
42
1,037
0
This Quarter
5
This FY
Total to Date
19
80
21
0
0
0
0
0
42
0
0
1
0
0
0
0
64
0
1
0
2
0
9
0
0
0
66
0
0
0
0
0
1
1
2
9
0
1
19
1
1
3
Through NSSP
4
0
1
2
19
1
1
5
80
4
5
21
Through Site-specific Project
9
42
1
2
3
16
0
1
1,182
68
459
48
Page 4 of 8
Line 1/IAAP- FWP
Quarterly Report
A
75
76
77
78
79
80
B
C
D
E
Through Site-specific Project
Beryllium Sensitization/Disease Testing
(initial screens)
Total Number of Individuals Tested
Total Number of Individuals with 1 Abnormal
BeLPT
Total Number of Individuals with 2 Abnormal
BeLPTs
Total Number of Individuals with 1 Abnormal
and 1+ Borderline BeLPTs
81
82
83 Audiograms
84 Total Number of Individuals Screened
Number of Individuals with Noise-induced
85 hearing loss (NIHL)
Number of Individuals with supplemental
86 definition of occupational NIHL
87
88 Follow-up Recommended
89 Potentially occupationally-related follow-up
90 Non-occupationally-related follow-up
This Quarter
8
0
G
Through NSSP
This FY
Total to Date
41
1,167
0
F
This Quarter
5
This FY
Total to Date
21
81
12
1
1
4
0
0
10
0
0
1
0
0
7
0
0
0
87
Through NSSP
0
1
14
0
75
0
1
9
0
0
0
0
0
Through NSSP
1
4
3
19
21
72
Through Site-specific Project
0
0
0
0
Through Site-specific Project
0
0
7
33
226
883
Page 5 of 8
Line 1/IAAP- FWP
Quarterly Report
A
Indicators of Interest in Program (3-year
91 follow-up)
92
Total Number of Respondents Pre1
93 Authorized/Scheduled for 3-yr follow-up
94
B
C
D
This Quarter
This FY
Total to Date
295
352
E
F
G
978
95 Participation Indicators (3-yr follow-up)
96 3-year Follow-up Screening Goal for this FY
180
97
This Quarter
This FY
Total to Date
Total number received 3-year follow-up
screening (total combined through site98 specific & NSSP)
80
227
499
Screened Through Primary/Site-Specific
99
80
225
497
Screened Through NSSP
100
0
2
2
Total number received 2 or more 3-year
101 follow-up exams
40
116
169
102 Total number of 3-year follow-up exams
80
227
636
103
Through Site-specific Project
104 On 3-yr follow-up:
This Quarter
Total to Date
105
74.44
73.74
106 Mean/Average Age at Exam (Male)
73.61
72.97
107 Mean/Average Age at Exam (Female)
54 - 92
52 - 94
108 Age Range (Male)
60 - 83
49 - 92
109 Age Range (Female)
Through NSSP
This Quarter
Total to Date
66.00
63 - 69
Page 6 of 8
Line 1/IAAP- FWP
Quarterly Report
A
B
C
D
E
F
G
110
111 Lab Studies/Findings (3-yr follow-up)
112
113 Chest X-Rays (3-yr follow-up)
114 Total Number of Individuals Tested
Number with Suspected Asbestosis without
115 pleural disease
Number with Suspected Asbestosis with
116 pleural disease
Number with Suspected Asbestos-related
117 pleural disease
118 Number with Suspected Silicosis
Number with Suspected Mixed Dust
119 Pneumoconiosis
Number with Suspected Pneumoconiosis,
120 not otherwise specified
Number with Suspicious Lung Nodules,
121 Nodes, Lesions (suspicious for cancer)
122
Pulmonary Function Tests (3-yr follow2
123 up)
124 Total Number of Individuals Tested
125 Number with Restrictive Pattern
126 Number with Obstructive Pattern
127 Number with Mixed Pattern
128
Through Site-specific Project
This Quarter
80
0
Through NSSP
This FY
Total to Date
221
322
This Quarter
0
This FY
2
Total to Date
2
1
4
0
0
0
0
0
4
0
0
0
0
0
0
0
5
0
0
0
0
0
0
0
0
1
5
0
0
0
0
1
1
0
0
0
0
0
1
0
0
0
80
10
22
6
223
14
80
18
300
20
116
20
0
0
0
0
2
0
1
0
2
0
1
0
Page 7 of 8
Line 1/IAAP- FWP
Quarterly Report
A
129
Beryllium Sensitization/Disease Testing
130 (3-yr follow-up)
131 Total Number of Individuals Tested
Total Number of Individuals with 1 Abnormal
132 BeLPT
Total Number of Individuals with 2 Abnormal
133 BeLPTs
Total Number of Individuals with 1 Abnormal
134 and 1+ Borderline BeLPTs
135
136 Follow-up Recommended
B
C
Through Site-specific Project
This Quarter
80
D
E
F
G
Through NSSP
This FY
Total to Date
214
480
This Quarter
0
This FY
2
Total to Date
2
0
0
4
0
0
0
0
0
2
0
0
0
0
0
0
0
0
0
0
2
0
2
Through Site-specific Project
0
1
137 Potentially occupationally-related follow-up
58
168
138 Non-occupationally-related follow-up
139
[1]
Re-screening exams provided 3+ yrs since initial exam, unless individual is
140 overly concerned.
[2]
141 If possible, please use the Caret classification system.
142
143
Through NSSP
7
235
0
0
Page 8 of 8
Notes/Comments/Qualifiers
39C, 48D, 61D, 71D, 81D, 99C, 99D, 101C, 101D,124D, 126C, 126D: Numbers may not add up to previous quarterly report due to
ongoing data cleaning efforts.
Line 25: Refers to new participants contacted my mail only.
55C: Max value corrected (data entry error).
Lines 62-68 & 115-121: 'This Quarter' and 'This FY' are not updated due to delay in the three occ med doctors reading the CXR
films. However, results will eventually be totaled in 'Total to Date.'
66D, 68D: Numbers updated due to the three occ med doctors deading the CXR films.
Line 93: Number of participants who are eligible for the 3-year or 6-year follow-up screening (i.e., their 3-year, 6-year or 9-year
window has opened).
Line 99: Reports all participants who had a 3-year, 6-year or 9-year follow-up screening.
Line 101: Reports all participants who have had multiple 3-year follow-up screenings (e.g., those who have had a 3- year and 6year follow-up screening, etc.).
102D: Reports total number of 3-year, 6-year AND 9-year follow-up screenings to date.
Lines 106-109 (age): Calculated from cells 99B and 99D.